Commercialization of research outputs
Research conducted at FNUSA-ICRC yields concrete outputs, new diagnostic and therapeutic methods and technologies, or new substances that can be used as pharmaceuticals. FNUSA-ICRC strives to commercialize these outputs, i.e. pass them on to manufacturers of pharmaceuticals or medical devices for commercial use.
For example, FNUSA-ICRC research has produced outputs in the form of a joint US patent for a new method and apparatus for the diagnosis of ventricular dyssynchrony, a patent for a drug with a potential use for prostate cancer treatment, and a joint patent application with the Mayo Clinic has been filed at the US Patent Office for a new method and apparatus for the treatment of cardiac arrhythmia. Additional patent applications are currently being prepared.
If you are preparing your own invention or innovation for commercialization, but you need help with completion, please contact our Technology Transfer Department.